Thane, India

Sadanand Hardeo Maurya

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Assia Chemical Industries Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sadanand Hardeo Maurya. Retrieved from https://idiyas.com/inventor/sadanand-hardeo-maurya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sadanand Hardeo Maurya: Innovator in Pharmaceutical Chemistry

Introduction

Sadanand Hardeo Maurya is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of medications.

Latest Patents

Maurya holds a patent for "Solid state forms of Eltrombopag choline." This patent includes processes for the preparation of these solid-state forms and the pharmaceutical compositions derived from them. His innovative work in this area has the potential to enhance the efficacy and stability of pharmaceutical products.

Career Highlights

Sadanand Hardeo Maurya is associated with Assia Chemical Industries Ltd., where he applies his expertise in pharmaceutical development. His work focuses on improving drug formulations and ensuring their effectiveness in clinical applications.

Collaborations

Maurya collaborates with talented professionals in his field, including Sharma Vijay Hariprasad and Nasir Ali Shafakat Ali. These collaborations foster a creative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Sadanand Hardeo Maurya's contributions to pharmaceutical chemistry, particularly through his patent on Eltrombopag choline, highlight his role as an innovator in the industry. His work continues to influence the development of effective pharmaceutical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…